Application Nr Approved Date Route Status External Links
ANDA040327 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Orphenadrine Citrate Extended-Release Tablets Are Indicated As An Adjunct To Rest, Physical Therapy And Other Measures For The Relief Of Discomfort Associated With Acute Painful Musculo Skeletal Conditions.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Orphenadrine Citrate ORPHENADRINE CITRATE ZINC155269

Comments